COVID-19 impact
Pharmetheus continues to monitor the challenges presented by the COVID-19 pandemic and its effects on our company and in the field of clinical drug development. Read more about our approach and latest updates here.
Pharmetheus continues to monitor the challenges presented by the COVID-19 pandemic and its effects on our company and in the field of clinical drug development. Read more about our approach and latest updates here.
Our CEO, Dr Peter A Milligan, has been interviewed by the Pharma Tech Outlook magazine. Read more about how we change the model informed drug
We are honoured that Pharmetheus has been listed as one of the top 10 pharma analytics companies in Europe by the Pharma Tech Outlook magazine
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..